Ty Gluckman, MD: Using Telemedicine to Improve Access to Care


The pandemic has removed some of the barriers of medicine.

Access to doctors has long been one of the biggest hurdles in medicine.

For example, someone living in New York City has inherent advantages in accessing top doctors over someone who may live in a more rural part of the country.

However, with the advent of telemedicine during the COVID-19 pandemic, some of these barriers that have long existed may be finally coming to a close.

In an interview with HCPLive® during Pri-Med West 2022 in Anaheim, Ty Gluckman, MD, Medical Director of the Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), said telemedicine has improved care for many, but there still remains some challenges.

For example, regulations make crossing state lines difficult for many.

In addition, not every disease can be treated over a video conferring call.

Gluckman said he is able to consult with patients about things like cholesterol, but there are some cardiovascular diseases that will still require in-person appointments, like patients with heart failure.

But overall, the advent of telehealth is a net positive.

“I would say the pandemic and telehealth has dramatically accelerated the ability to overcome some challenges of access,” he said.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
© 2024 MJH Life Sciences

All rights reserved.